DSM - repurchase of shares (16-20 March 2020)
DSM repurchased 239,127 shares from 16 to 20 March 2020 at an average price of €89.77.
24 Mar 2020
It is necessary for DSM to undertake regular share buy-back programs?to cover its commitment to shareholders wishing to receive their dividend in the form of ordinary shares, as well as to fulfill its obligations under share-based compensation plans.
DSM obtains approval for the company to repurchase its own shares each year at the Annual General Meeting of Shareholders. Each year we also obtain approval to reduce the company's issued capital by cancellation of its shares up to a maximum of the number that is, or will be bought by, the company.
With effect from 2 March 2020 DSM is repurchasing?1,400,000 ordinary shares to cover commitments under share-based compensation plans and for stock dividend1 as first announced on 2 March.
In accordance with Article 2(2) of the EU Regulation that contains technical standards for buyback programs, DSM details progress via weekly press releases. This?Daily Transaction Details Share Repurchase Program announced 2 March 2020?spreadsheet will be updated each week during the course of the program.
DSM repurchased 239,127 shares from 16 to 20 March 2020 at an average price of €89.77.
24 Mar 2020
DSM repurchased 705,494 shares from 9 to 13 March 2020 at an average price of €96.33.
17 Mar 2020
DSM repurchased a total of?9,238,971 shares for a combined consideration of €1.01 billion in accordance with the repurchase program announced on 14 March 20191. This?Daily Transaction Details Share Repurchase Program?spreadsheet was updated and published weekly during the course of the program.
DSM repurchased a total of 1,100,000 shares for a combined consideration of €98.9 million in accordance with the repurchase program announced on 13 August 2018.?This?Daily Transaction Details 1.1m Share Repurchase Program spreadsheet was updated and published weekly during the course of the program.
DSM repurchased a total of 1,600,000 shares for a combined consideration of €136.7 million in accordance with the repurchase program announced on 19 March 2018. This Daily Transaction Details 1.6m Share Repurchase Program spreadsheet was updated and published weekly during the course of the program.
DSM repurchased a total of 1,600,000 shares for a combined €109.3 million in accordance with the repurchase program announced on 14 August 2017.?This?Daily Transaction Details 1.6m Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.
DSM repurchased a total of 2,900,000 shares for a combined €187.2 million in accordance with the repurchase program announced on 13 March 2017. This?Daily transaction details 2.9m Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.
DSM repurchased a total of 1,700,000 shares for a combined €96.0 million in accordance with the repurchase program announced on 4 November 2016. This?Daily Transaction Details 1.7m Share Repurchase Program spreadsheet was updated weekly during the course of the buy-back program.
DSM repurchased a total of 3,500,000 shares for a combined €176.8 million in accordance with the repurchase program announced on 22 February 2016 (as amended on 10 June 2016). DSM informed the market about the program's progress via weekly press releases.
DSM repurchased a total of 2,300,000 shares for a combined €122.5 million in accordance with the repurchase program announced on 14 May 2015. DSM informed the market about the program's progress via weekly press releases.
1)?The repurchase of 1,400,000 ordinary shares announced on 2 March 2020 is in addition to the program to spend €1 billion repurchasing shares?to reduce the company's issued share capital.?In 2019 DSM repurchased 5.4 million shares for a total consideration of €600 million under this program and intends repurchasing the remaining €400 million during the first half year of 2020.
DSM declares that the Netherlands is its "Home Member State", as required by article 5:25a (2) of the Dutch Financial Supervision Act. This article obliges all listed companies to publicly announce which country is their "home member state" (as referred to in article 5:25a(1) sub c of the Dutch Financial Supervision Act) for purposes of regulation of their disclosure obligations under the EU Transparency Directive. Pursuant to section 5:25a of the Dutch Financial Supervision Act, Royal DSM has notified the?Dutch Authority for the Financial Markets (AFM).
Key facts and figures about DSM, our business and our people, planet & profit performance in one overview.
DSM's recent dividend history.
The sell-side analysts covering DSM and latest Vara consensus figures.